Guggenheim Initiates Coverage On Entera Bio with Buy Rating, Announces Price Target of $11

Benzinga · 3d ago
Guggenheim analyst Vamil Divan initiates coverage on Entera Bio (NASDAQ:ENTX) with a Buy rating and announces Price Target of $11.